• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 3DMAX LIGHT; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 3DMAX LIGHT; SURGICAL MESH Back to Search Results
Catalog Number 0117311
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Hematoma (1884); Seroma (2069)
Date of Event 04/01/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Based on the contents of the article, no conclusions can be made.The information provided in the article indicates that some patients experienced post-operative complications.The information obtained is limited to the content of the article.The article does not report any specific device malfunction or post-op complications were caused or contributed to the use of the 3dmax light mesh.The adverse reaction section of the instructions-for-use (ifu), supplied with the device identifies seroma and hematoma as possible complications.No lot number has been provided; therefore, a review of the manufacturing records is not possible.Note, the date of event (01-apr-2022) is considered to be a best estimate.This mdr represents the 3dmax light mesh (left).An additional mdr has been submitted to document information related to the 3dmax light mesh (right).Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
Per journal article: "comparison of single-incision totally extraperitoneal repair of inguinal hernia and conventional multi-port totally extraperitoneal repair: a retrospective study".This retrospective single-center study evaluated the feasibility, safety, and clinical outcomes of single-incision totally extraperitoneal repair (sils-tep) compared with conventional three-port tep repair for inguinal hernia treatment.A total of 102 patients who underwent tep repair between (b)(6) 2022 and (b)(6) 2025 were included.The study assessed operative time, postoperative pain, complications, chronic pain, recurrence, and hospitalization outcomes.The study included 102 patients (62 patients underwent sils-tep and 40 patients underwent conventional three-port tep).The mean age was 66 years in the sils-tep group and 68 years in the three-port tep group.Most patients were male (87% and 93%, respectively).Both groups had comparable baseline characteristics and hernia classifications.All patients underwent laparoscopic totally extraperitoneal (tep) inguinal hernia repair under general anesthesia.Site included unilateral and bilateral.In the sils-tep group, surgery was performed through a single approximately 2-cm umbilical incision using a lap protector and ez access platform containing three 5-mm ports.In the three-port tep group, one 12-mm port and two 5-mm ports were inserted sequentially through separate incisions.For indirect hernias, the hernia sac was closed using a roeder's knot.In both groups, 3dmax light mesh large was placed in the extraperitoneal space to adequately cover the myopectineal orifice.The mesh was positioned carefully during deflation of the extraperitoneal space to prevent inversion.No specific mesh fixation technique was described.The major difference between the groups was the number of access incisions and port placement technique, while the same mesh type and tep repair principles were used in both groups.Post operative complication include (1) peritoneal injury requiring repair occurred in 6 patients (4 in sils-tep and 2 in tep group), these injuries were managed intraoperatively with endoscopic suturing repair.(2) seroma: 6 cases (9.7%) in sils-tep and 4 cases (10.0%) in three-port tep.(3) hematoma: 1 case (1.6%) in sils-tep and 1 case (2.5%) in three-port tep.It is concluded that sils-tep is a safe and feasible alternative to conventional three-port tep repair, providing equivalent clinical outcomes with a significantly shorter operative time and improved cosmetic results.Note: there is no information provided in the article indicating that the device caused or contributed to the postoperative patient complication(s).However, as postoperative complications did present and some requiring medical/surgical intervention we are reporting this as a serious injury mdr.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
3DMAX LIGHT
Common Device Name
SURGICAL MESH
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
BARD SHANNON LIMITED -3005636544
san geronimo industrial park
lot #1, road #3, km 79.7
humacao PR 00791
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key25758013
Report Number1213643-2026-00878
Device Sequence Number9787285
Product Code FTL
UDI-Device Identifier00801741031038
UDI-Public(01)00801741031038
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K091659
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Literature,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number0117311
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/25/2026
Initial Report FDA Received Date07/09/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-